Great summary @wellzi !Very strong cash position indeed, and at...

Great summary @wellzi !
Very strong cash position indeed, and at current cash outflow rate as you mentioned, even with no further revenue, they could survive at least 1 year but we know that this year many deals and partnerships will begin bringing in revenue as users adopt MYQ tech and we see a higher uptake in users by leveraging the network of the partner companies! Once we are CF+, we won't need any more capital raises, which would dilute the shares on Issue further.

Market capwise, I find MYQ is hard to value because they are in so many sectors, fitness, life/health insurance, apparel, ehealth, medtech such as derma scans, etc. But as you mentioned there are plenty of companies still at a loss which the market is willing to pay multiples for such as APT. And on the NASDAQ, we know investors have been paying for tech companies at a premium even while they are loss making for years such as Tesla, Lyft, Uber, Snapchat etc. With MYQ cash flow positive we should hopefully see large groups of US investors getting at a floor price of around $2+ and hold on much higher as the company sees growth in revenue, gross profits and EBITDA.

But for a company its size, at under $165M MC, the growth potential is definitely there and as we see more deals we will hopefully rerate the SP to the upside significantly higher than where we today. $300M is a great start! Bring on 2021!